Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300

by Mauro Rosales, George V. Pérez, Ailyn C. Ramón, Yiliam Cruz, Arielis Rodríguez-Ulloa, Vladimir Besada, Yassel Ramos, Dania Vázquez-Blomquist, Evelin Caballero, Daylen Aguilar, Luis J. González, Katharina Zettl, Jacek R. Wiśniewski, Ke Yang, Yasser Perera, Silvio E. Perea
Published 2021-07-01